| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics SA | Director | Common Shares | 108K | $388K | $3.58 | Jun 13, 2025 | Direct |
| Merus N.V. | Director | Share Option (right to buy) | 13.2K | $120K | $13.52 | May 22, 2025 | Direct |
| Prelude Therapeutics Inc | Director | Director Stock Option (Right to Buy) | 121K | Nov 5, 2025 | Direct | ||
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 25, 2025 | Direct |